Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (211-220 of 336) with videos related to

Pageof 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancerFrancisco J Esteva, John Glaspy, Said Baidas, et al.
Breast Cancer Research and Treatment|October 9, 2007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN Lynn Henry, Jon T Giles, Dennis Ang, et al.
Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.
Archives of Pathology & Laboratory Medicine|January 7, 2009
Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breastSusan C Lester, Shikha Bose, Yunn-Yi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancerMassimo Cristofanilli, Daniel F Hayes, G Thomas Budd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2023
Novel Prognostic Staging System for Patients With De Novo Metastatic Breast CancerJennifer K Plichta, Samantha M Thomas, Daniel F Hayes, et al.
British Journal of Clinical Pharmacology|February 10, 2016
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226Daniel L Hertz, William E Barlow, Kelley M Kidwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 TrialCostanza Paoletti, William E Barlow, Erin F Cobain, et al.
Physiological Genomics|August 21, 2016
ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumorsDaniel L Hertz, N Lynn Henry, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment|November 13, 2009
Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aidAngela Fagerlin, Brian J Zikmund-Fisher, Vijayan Nair, et al.
Pageof 34

Showing results (211-220 of 336) with videos related to

Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Multicenter phase II study of oral bexarotene for patients with metastatic breast cancerFrancisco J Esteva, John Glaspy, Said Baidas, et al.
Breast Cancer Research and Treatment|October 9, 2007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN Lynn Henry, Jon T Giles, Dennis Ang, et al.
Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.
Archives of Pathology & Laboratory Medicine|January 7, 2009
Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breastSusan C Lester, Shikha Bose, Yunn-Yi Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancerMassimo Cristofanilli, Daniel F Hayes, G Thomas Budd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2023
Novel Prognostic Staging System for Patients With De Novo Metastatic Breast CancerJennifer K Plichta, Samantha M Thomas, Daniel F Hayes, et al.
British Journal of Clinical Pharmacology|February 10, 2016
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226Daniel L Hertz, William E Barlow, Kelley M Kidwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2021
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 TrialCostanza Paoletti, William E Barlow, Erin F Cobain, et al.
Physiological Genomics|August 21, 2016
ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumorsDaniel L Hertz, N Lynn Henry, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment|November 13, 2009
Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aidAngela Fagerlin, Brian J Zikmund-Fisher, Vijayan Nair, et al.
Pageof 34